vs
Side-by-side financial comparison of International General Insurance Holdings Ltd. (IGIC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
International General Insurance Holdings Ltd. is the larger business by last-quarter revenue ($403.8M vs $37.2M, roughly 10.8× Organogenesis Holdings Inc.).
China Taiping Insurance Holdings Company Limited (CTIH) formerly China Insurance International Holdings Company Limited (CIIH), is a Chinese insurance conglomerate. The company has strong Chinese Central Government background despite being incorporated in Hong Kong. It is considered as a red chip company.
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
IGIC vs ORGO — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $403.8M | $37.2M |
| Net Profit | $105.1M | — |
| Gross Margin | — | 30.8% |
| Operating Margin | — | -185.1% |
| Net Margin | 26.0% | — |
| Revenue YoY | — | -57.1% |
| Net Profit YoY | — | — |
| EPS (diluted) | $2.31 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $37.2M | ||
| Q4 25 | — | $225.6M | ||
| Q3 25 | $403.8M | $150.9M | ||
| Q2 25 | $261.9M | $101.0M | ||
| Q1 25 | — | $86.7M | ||
| Q4 24 | — | $126.7M | ||
| Q3 24 | $369.6M | $115.2M | ||
| Q2 24 | $265.8M | $130.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $43.7M | ||
| Q3 25 | $105.1M | $21.6M | ||
| Q2 25 | $61.4M | $-9.4M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | $-134.4M | $12.3M | ||
| Q2 24 | $70.7M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | — | 28.1% | ||
| Q3 25 | — | 13.7% | ||
| Q2 25 | 24.2% | -12.5% | ||
| Q1 25 | — | -30.9% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | -73.3% | -10.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.4% | ||
| Q3 25 | 26.0% | 14.3% | ||
| Q2 25 | 23.5% | -9.3% | ||
| Q1 25 | — | -21.7% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -36.4% | 10.7% | ||
| Q2 24 | 26.6% | -13.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.31 | ||
| Q3 25 | $2.31 | $0.11 | ||
| Q2 25 | $1.36 | $-0.10 | ||
| Q1 25 | — | $-0.17 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $1.82 | $0.09 | ||
| Q2 24 | $1.55 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $244.7M | $91.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $654.8M | — |
| Total Assets | $2.0B | $520.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $91.4M | ||
| Q4 25 | — | $93.7M | ||
| Q3 25 | $244.7M | $63.7M | ||
| Q2 25 | $164.8M | $73.1M | ||
| Q1 25 | — | $110.0M | ||
| Q4 24 | — | $135.6M | ||
| Q3 24 | $219.2M | $94.3M | ||
| Q2 24 | $237.3M | $89.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $300.1M | ||
| Q3 25 | $654.8M | $255.1M | ||
| Q2 25 | $662.3M | $233.2M | ||
| Q1 25 | — | $242.9M | ||
| Q4 24 | — | $262.9M | ||
| Q3 24 | $540.5M | $278.5M | ||
| Q2 24 | $588.2M | $263.5M |
| Q1 26 | — | $520.0M | ||
| Q4 25 | — | $598.7M | ||
| Q3 25 | $2.0B | $509.8M | ||
| Q2 25 | $2.1B | $461.1M | ||
| Q1 25 | — | $467.4M | ||
| Q4 24 | — | $497.9M | ||
| Q3 24 | $1.8B | $446.3M | ||
| Q2 24 | $2.0B | $443.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
